Future Science Group Launches Open Access Journal

(PRWEB UK) 23 January 2015

Future Science Open will consider publication of all original research articles that have been conducted with scientific rigor and research integrity. All articles submitted to Future Science Open will undergo peer review by a minimum of three independent experts. The journal will also feature review articles, editorials and perspective pieces, providing readers with a leading source of commentary and analysis in the field of biomedical research.

We are pleased to offer our first open access journal, and are eager to use this model to make high quality research available to the broadest possible audience. said Phil Garner, managing director.

Senior editors of the journal include Benoit Arsenault, Universit Laval, Canada; Ian A Blair, University of Pennsylvania, USA; and Paul Span, Radboud University Nijmegen Medical Centre, The Netherlands. They are joined by a young ambassadors panel, composed of early career researchers, and an international editorial board.

Future Science Open provides a truly inter-disciplinary forum for reporting studies that are of importance to human health. said Ian Blair, senior editor.

The journal follows a gold open access model, publishing all articles under the Creative Commons CC-BY license to allow maximum dissemination. Authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP2.

Future Science Open is actively soliciting contributions of original research, reviews and perspective articles and is waiving fees during its launch phase. To submit an article, or for further information, contact the Launch Editor Francesca Lake: f.lake(at)futuremedicine(dot)com.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSGs portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.futuresciencegroup.com

See the original post here:
Future Science Group Launches Open Access Journal